Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature.
Pierre L BonnetClaire V HoffmannNathan Le NanLorenn BellamyGautier HoarauPierre FloriMagalie DemarNicolas ArgyFlorent MorioSolène Le GalGilles NevezPublished in: Medical mycology (2023)
Pneumocystis jirovecii is a transmissible fungus responsible for severe pneumonia (Pneumocystis pneumonia [PCP]) in immunocompromised patients. Missense mutations due to atovaquone selective pressure have been identified on cytochrome b (CYB) gene of P. jirovecii. It was recently shown that atovaquone prophylaxis can lead to the selection of specific P. jirovecii cytochrome b mutants potentially resistant to atovaquone among organ transplant recipients. In this context, our objectives were to provide data on P. jirovecii cytochrome b mutants and putative selective pressure exerted by atovaquone on P. jirovecii organisms in France. A total of 123 patients (124 P. jirovecii specimens) from four metropolitan hospitals and two overseas hospitals were retrospectively enrolled. Fourteen patients had prior exposure to atovaquone whereas 109 patients did not, at the time of P. jirovecii detection. A 638 base-pair fragment of the CYB gene of P. jirovecii was amplified and sequenced. A total of 10 SNPs was identified. Both missense mutations C431T (Ala144Val) and C823T (Leu275Phe) located at the Qo active site of the enzyme, were significantly associated with prior atovaquone exposure, these mutations being conversely incidental in absence of prior atovaquone exposure (P < 0.001). Considering that the aforementioned hospitals may be representative of the national territory, these findings suggest that overall presence of P. jirovecii cytochrome b mutants remains low in France.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- healthcare
- gene expression
- intensive care unit
- patient reported outcomes
- autism spectrum disorder
- genome wide
- copy number
- early onset
- intellectual disability
- artificial intelligence
- deep learning
- big data
- gram negative
- loop mediated isothermal amplification
- drug induced